Remove 2010 Remove Doctors Remove Physicians
article thumbnail

Do patients care about accelerated approval drugs?

World of DTC Marketing

85% of accelerated approvals from 2010 to 2020 were for oncology indications. Of course, they should, but in the end, it’s going to come down to trust in their doctor and the FDA. of approvals), cancer (35.6%), and other rare diseases (24.7%). .” of approvals), cancer (35.6%), and other rare diseases (24.7%).

Patients 200
article thumbnail

How AI Can Help Medical Science Liaisons Juggle Their Ever-Growing Responsibilities

PM360

1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. Orchestrated omnichannel engagement has grown into a buzz phrase for commercial teams ever since they started using digital communications channels to engage with doctors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top 10 Best Telemedicine Companies in the USA

Medico Reach

Understandably, almost 30% of Americans skipped all doctor visits last year, given the spiraling price of healthcare and the increasing complexity of our daily lives. Physicians and patients continue to have a very positive opinion of the organization. Doctor on Demand Headquarters: San Francisco, California Revenue: $75.9

Doctors 40
article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. Patients may be reluctant to switch to biosimilars and doctors may have limited incentives to choose biosimilars. Further, there remains scepticism on the efficacy and safety of biosimilars.

article thumbnail

Exploring How COVID-19 Has Accelerated Digital in Healthcare: A Re-cap of the PMN Innovation Summit

Pharma Marketing Network

Patients and doctors went from trying to make sense of the platform to full-blown adoption where practices continue to incorporate it as an integral part of the go-to-market model. Telehealth has brought positive change for both patients and doctors. Digital Therapeutics have been around from as far back as 2010.

article thumbnail

Exploring How COVID-19 Has Accelerated Digital in Healthcare: A Re-cap of the PMN Innovation Summit

Pharma Marketing Network

Patients and doctors went from trying to make sense of the platform to full-blown adoption where practices continue to incorporate it as an integral part of the go-to-market model. Telehealth has brought positive change for both patients and doctors. Digital Therapeutics have been around from as far back as 2010.

article thumbnail

Patient insights into the decentralisation of clinical trials

European Pharmaceutical Review

Without the pressure of being in front of a doctor, they can take their time. There is the physician’s explanation, plus an extra written explanation and signature as three different moments, and two of them are at home. The ‘disease expert’, is usually considered to be the medical expert of the disease – the physician.